SCHEMBL2857149

SCHEMBL2857149

O=C(NCC1CCC1)c1ccnc(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.54
TAS1R1 Q7RTX1 1/20 0.54
TAS1R2 Q8TE23 1/20 0.54
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HDAC6 Q9UBN7 3/20 0.51
MLYCD O95822 1/20 0.49
MAPK1 P28482 1/20 0.48
POLB P06746 1/20 0.47
AR P10275 2/20 0.47
PREP P48147 1/20 0.47
FAP Q12884 1/20 0.47
ACACB O00763 1/20 0.47
ACACA Q13085 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CA2 P00918 1/20 0.45
ROCK2 O75116 1/20 0.45
NAMPT P43490 1/20 0.45
MAPK14 Q16539 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2858442 0.97 TAS1R3 (0.57) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL2863438 0.96 MEN1 (0.56) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL2863458 0.94 TAS1R3 (0.53) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL15962660 0.89 TAS1R3 (0.53) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL15962770 0.88 TAS1R3 (0.54) TAS1R3TAS1R1TAS1R2ARPREP
SCHEMBL15955949 0.88 TAS1R3 (0.54) TAS1R3TAS1R1TAS1R2ARPREP
SCHEMBL15962769 0.88 TAS1R3 (0.54) TAS1R3TAS1R1TAS1R2ARPREP
SCHEMBL15962715 0.85 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2ARPREP
SCHEMBL2868271 0.83 TAS1R3 (0.54) TAS1R3TAS1R1TAS1R2MEN1KMT2A
SCHEMBL18458807 0.81 MEN1 (0.55) MEN1KMT2AHDAC6MLYCDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014124988-A1 PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES SYNGENTA LIMITED (GB) 2014-08-21 WO disclosed
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
EP-2174931-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME Sumitomo Chemical Company, Limited (JP) 2010-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME NAAA, NAT1, SAT1 TAS1R3 4053/4885TAS1R1 3002/4885TAS1R2 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.